Literature DB >> 21466991

Comparison of the effects of sevoflurane and isoflurane on myocardial protection in coronary bypass surgery.

Dilek Ceyhan1, Belkıs Tanrıverdi, Ayten Bilir.   

Abstract

OBJECTIVE: The aim of this prospective randomized study was to compare the myocardial protective effects of sevoflurane and isoflurane during coronary bypass surgery.
METHODS: After induction of general anesthesia with etomidate 0.3 mg/kg, a bolus dose of pancuronium 0.1 mg/kg and remifentanil 1 mcg/kg was administered. For the maintenance of anesthesia, patients received either sevoflurane (n=20) at 2-4% or isoflurane (n=20) at 1-2% . Arterial blood samples were obtained as follows: before induction of anesthesia, after aortic unclamping, at postoperative period. Troponin-T, creatine kinase (CK), and creatine kinase-MB (CKMB) values were measured in all obtained samples. Statistical analysis was performed using two-way ANOVA analysis and Mann-Whitney test.
RESULTS: Heart rate was significantly higher in the sevoflurane group during the aortic side-clamp period, at the 10th minute and 20th minute after cardiopulmonary bypass (CPB) ending. The CK-MB values at 24th postoperative hour in the sevoflurane group were found to be significantly lower from the isoflurane group. The troponin-T values following the removal of the cross-clamp (1.015 (0.935-1.850) ng/ml vs 1.469 (1.290-1.645) ng/ml, p<0.001) and those at the 24th postoperative hour (5.345±0.654 ng/ml vs 8.715±1.020 ng/ml, p<0.001) were significantly lower in the sevoflurane group when compared to those in the isoflurane group.
CONCLUSION: Sevoflurane provides a better myocardial protection than isoflurane, as may be inferred by the lower levels of the myocardial injury markers troponin-T and CK-MB observed with sevoflurane.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466991     DOI: 10.5152/akd.2011.059

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  5 in total

1.  Totally thoracoscopic repair of atrial septal defect reduces systemic inflammatory reaction and myocardial damage in initial patients.

Authors:  Xiang Liu; Yanhu Wu; Jinfu Zhu; Xiaoxia Lv; Yihu Tang; Jie Sun; Shijiang Zhang
Journal:  Eur J Med Res       Date:  2014-03-11       Impact factor: 2.175

Review 2.  The Impact of Volatile Anesthetic Choice on Postoperative Outcomes of Cardiac Surgery: A Meta-Analysis.

Authors:  Andres Zorrilla-Vaca; Rafael A Núñez-Patiño; Valentina Torres; Yudy Salazar-Gomez
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

3.  Sevoflurane post-conditioning reduces rat myocardial ischemia reperfusion injury through an increase in NOS and a decrease in phopshorylated NHE1 levels.

Authors:  Jianfang Cao; Hong Xie; Ying Sun; Jiang Zhu; Ming Ying; Shigang Qiao; Qin Shao; Haorong Wu; Chen Wang
Journal:  Int J Mol Med       Date:  2015-10-12       Impact factor: 4.101

4.  Protective effect of sevoflurane on myocardial ischemia-reperfusion injury in rat hearts and its impact on HIF-1α and caspase-3 expression.

Authors:  Tao Zhou; Shanliang Guo; Shaolin Wang; Qiong Li; Mingsheng Zhang
Journal:  Exp Ther Med       Date:  2017-08-30       Impact factor: 2.447

Review 5.  Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis.

Authors:  Hossein Hosseinifard; Nashmil Ghadimi; Sara Kaveh; Hossein Shabaninejad; Alaadine Lijassi; Rasoul Azarfarin
Journal:  J Cardiovasc Thorac Res       Date:  2020-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.